Along those lines, we screened a kinase inhibitor library and found that a combination of the inhibitors for two kinases, Rho-associated protein kinase (ROCK) and mammalian target of rapamycin (mTOR), can reprogram human breast cancer cells into progenitor cells. The gene discussed is MTOR; the disease is breast carcinoma.